• Home
  • AACR-CRI Lloyd J. Old Award in Cancer Immunology: Winners

​AACR-CRI Lloyd J. Old Award in Cancer Immunology Recipients

This award recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.

Sixth Award Recipient
Antoni Ribas, MD, PhD
Professor of Medicine, Surgery, Molecular and Medical Pharmacology
Director, Tumor Immunology Program, Jonsson Comprehensive Cancer Center
Director, Parker Institute for Cancer Immunotherapy Center at UCLA
University of California Los Angeles
Los Angeles, California

Dr. Ribas delivered his award lecture titled "Genetic Engineering of Anticancer Immune Responses" at the AACR Annual Meeting 2018 in Chicago, Illinois. The award lecture was held Tuesday, April 17, 2018, in the McCormick Place North/South Convention Center.

The AACR-CRI Lloyd J. Old Award in Cancer Immunology was established in honor of the late Lloyd J. Old, MD, who is considered the “Founding Father of Modern Tumor Immunology.” Dr. Old’s outstanding research in the field of cancer immunology, as well as his decades of leadership in fostering the field, has had a far-reaching impact on cancer. This award is intended to recognize an active cancer immunologist who, like Dr. Old, has done outstanding, innovative, and impactful research in cancer immunology.

Antoni Ribas, MD, PhD, is honored for groundbreaking contributions to the successful development of checkpoint inhibitor immunotherapy for patients with metastatic melanoma, which have dramatically changed the treatment options for patients with melanoma and many other cancers.

As a recognized leader in clinical trials with anti-PD1 antibodies, Dr. Ribas led the clinical development of pembrolizumab, which was the first anti-PD1 approved by the FDA for any cancer. He has defined mechanisms that lead to response and acquired resistance to PD-1 blockade therapies. His impressive body of work has earned him the reputation as a true pioneer in the field.

Dr. Ribas is professor of medicine, professor of surgery, and professor of molecular and medical pharmacology at the University of California Los Angeles (UCLA); director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC); and the chair of the Melanoma Committee at SWOG. He trained at the University of Barcelona in Spain, and has undergone postdoctoral training at UCLA.

Dr. Ribas is an elected member of the American Society of Clinical Investigation (ASCI), a member of the Royal Academy of Medicine of Catalonia, has a Doctor Honoris Causa from the University of Buenos Aires, the recipient of an AACR Richard and Hinda Rosenthal Memorial Award and a NCI Outstanding Investigator Award.

Antoni Ribas, MD PhD receives award.jpg

Award Recipients

  • 2017: Olivera J. Finn
  • 2016: Ronald Levy
  • 2015: Carl H. June
  • 2014: Robert D. Schreiber
  • 2013: James P. Allison